Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $1.2 Million - $1.56 Million
-30,000 Reduced 33.33%
60,000 $2.4 Million
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $3.28 Million - $4.29 Million
90,000 New
90,000 $4.29 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $1.16 Million - $1.41 Million
-30,000 Reduced 50.0%
30,000 $1.36 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $1.01 Million - $1.24 Million
30,000 Added 100.0%
60,000 $2.14 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $1.1 Million - $1.46 Million
30,000 New
30,000 $1.33 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $1.72 Million - $2.13 Million
-57,500 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $4.22 Million - $5.1 Million
-125,800 Reduced 68.63%
57,500 $1.93 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $5.29 Million - $7.24 Million
153,300 Added 511.0%
183,300 $7.31 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $5.72 Million - $8.58 Million
-134,600 Reduced 81.77%
30,000 $1.35 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $2.79 Million - $3.71 Million
61,600 Added 59.81%
164,600 $9.31 Million
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $142,350 - $188,850
3,000 Added 3.0%
103,000 $4.89 Million
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $4.69 Million - $6.11 Million
100,000 New
100,000 $5.9 Million
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $2.97 Million - $3.63 Million
-50,300 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$62.09 - $86.14 $3.4 Million - $4.71 Million
-54,700 Reduced 52.1%
50,300 $3.23 Million
Q1 2019

May 14, 2019

BUY
$52.92 - $81.17 $5.56 Million - $8.52 Million
105,000 New
105,000 $8.52 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.